Live from the NIH registry
Studies recruiting near Lansing right now
Top 25 of 178 recruiting studies, sorted by proximity — each links to its official registry page
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Sepsis, Systemic Inflammatory Response Syndrome
N/A
Observational 2,500 participants sought
University of Michigan Health/Sparrow (name change only) — Lansing, Michigan (1.3 mi)
· Sponsor: Michigan State University
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
American Arthritis and Rheumatology Associates -Mi PLLC — Okemos, Michigan (6.8 mi)
· Sponsor: University of Alabama at Birmingham
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Lansing, Michigan (1.3 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
MSU Center for Bleeding and Clotting Disorders — Lansing, Michigan (1.3 mi)
· Sponsor: American Thrombosis and Hemostasis Network
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
Michigan State University-Department of Neurology — East Lansing, Michigan (4.2 mi)
· Sponsor: Novartis Pharmaceuticals
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
Multiple Myeloma
Phase 2
Interventional 60 participants sought
KCI at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: American Society of Clinical Oncology
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
N/A
Observational 150 participants sought
Sparrow Cancer Center — Lansing, Michigan (1.3 mi)
· Sponsor: Bayer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 600 participants sought
Advanced Rheumatology PC | Lansing, MI — Lansing, Michigan (1.3 mi)
· Sponsor: Takeda
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Lansing, Michigan (1.3 mi)
· Sponsor: Medtronic
Treating Chronic Cervicogenic Head and Neck Pain
Cervicogenic Headache, Neck Pain, Posterior
Phase 1, Phase 2
Interventional 30 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
UMH-Sparrow Clinical Research — Lansing, Michigan (1.3 mi)
· Sponsor: Orchestra BioMed, Inc
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
Parkinson Disease, Atypical Parkinsonism
N/A
Interventional 100 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3
Interventional 160 participants sought
Michigan State University- Site Number : 8400038 — East Lansing, Michigan (4.2 mi)
· Sponsor: Sanofi
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Children's Oncology Group